Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sep 2017 4:47 AM GMTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...